Improving vaccine design by targeting specific parts of viruses.
Manipulating Epitope Immunodominance and Tracking B-cell-Antigen Interactions for Vaccine Design.
['FUNDING_OTHER'] · WISTAR INSTITUTE · NIH-10468492
This study is working on creating better vaccines for viruses like HIV and the flu by focusing on parts of the virus that don’t change, so that people can have stronger protection against different strains of these viruses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WISTAR INSTITUTE (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10468492 on ClinicalTrials.gov |
What this research studies
This research focuses on developing vaccines that can effectively combat rapidly mutating viruses like HIV-1 and influenza. It aims to identify and manipulate specific regions of these viruses, known as conserved epitopes, which remain unchanged despite mutations. By engineering viral components to enhance the immune response to these critical areas, the research seeks to create vaccines that can provide broad protection against various viral strains. Patients may benefit from a more effective vaccine that can adapt to the evolving nature of these viruses.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for infections from rapidly mutating viruses, such as those living with HIV or in areas with high influenza prevalence.
Not a fit: Patients with infections caused by non-mutating viruses or those who are not at risk for viral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of vaccines that provide long-lasting protection against highly mutable viruses.
How similar studies have performed: Previous research has shown promise in targeting conserved epitopes for vaccine development, indicating potential success for this approach.
Where this research is happening
PHILADELPHIA, UNITED STATES
- WISTAR INSTITUTE — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ESCOLANO, AMELIA — WISTAR INSTITUTE
- Study coordinator: ESCOLANO, AMELIA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.